Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001562180-20-006684)

Filing Details

Accession Number:
0001562180-20-006684
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 20:01:26
Reporting Period:
2020-11-09
Accepted Time:
2020-11-12 20:01:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
897448 Amarin Corp Plc AMRN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1199637 F John Thero C/O Amarin Pharma, Inc.
440 Us Highway 22
Bridgewater NJ 08807		 President And Ceo No No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-11-09 134,739 $3.40 2,691,144 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-10 615,261 $3.40 3,306,405 No 4 M Direct
Ordinary Shares Disposition 2020-11-10 153,840 $4.13 3,152,565 No 4 S Direct
Ordinary Shares Disposition 2020-11-11 413,565 $4.07 2,739,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2020-11-09 134,739 $0.00 134,739 $3.40
Ordinary Shares Stock Option (Right to Buy) Disposition 2020-11-10 615,261 $0.00 615,261 $3.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
615,261 2020-11-10 No 4 M Direct
0 2020-11-10 No 4 M Direct
Footnotes
  1. Acquisitions reported in this Form 4 pertain to exercises of stock options scheduled to expire on Nov. 10, 2020. In the first of the reported acquisitions, dated Nov. 9, 2020, 134,739 shares were acquired for $500,000, in cash, covering the exercise price of the stock options and the related taxes. The second acquisition, dated Nov. 10, 2020, involved shares acquired by the Reporting Person for cash offset by proceeds from sales of a portion of the acquired shares with the net remaining shares, after paying for cost for this second acquisition including taxes, added to the holdings of the Reporting Person. The result of these transactions, for cash and other consideration paid, was a net increase in shares held by the Reporting Person of 182,595 shares.
  2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.01 to $4.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. Please see the section titled "Remarks" below for additional information.
  6. The stock option granted to the Reporting Person is fully vested as of the date hereof.